{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:25:28Z","timestamp":1754162728558,"version":"3.41.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,30]]},"DOI":"10.7759\/cureus.89059","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:21:38Z","timestamp":1753885298000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical Presentation of Multidrug-Resistant Acinetobacter baumannii Pneumonia in a Post-Surgical ICU Patient: A Case Report"],"prefix":"10.7759","author":[{"given":"Zaina","family":"Rawashdeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marah J","family":"Alshatarat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil G","family":"Daradkeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Awwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara H","family":"Sawalha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317798","article-title":"Predominance of extensively-drug resistant Acinetobacter baumannii carrying bla OXA-23 in Jordanian patients admitted to the intensive care units","volume":"20","author":"Ababneh Q","year":"2025","unstructured":"Ababneh Q, Aldaken N, Jaradat Z, et al.. Predominance of extensively-drug resistant Acinetobacter baumannii carrying bla OXA-23 in Jordanian patients admitted to the intensive care units. PLoS One. 2025, 20:e0317798. 10.1371\/journal.pone.0317798","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2024.01.018","article-title":"Multi-drug resistant Acinetobacter baumannii: phenotypic and genotypic resistance profiles and the associated risk factors in teaching hospital in Jordan","volume":"17","author":"Gharaibeh MH","year":"2024","unstructured":"Gharaibeh MH, Abandeh YM, Elnasser ZA, Lafi SQ, Obeidat HM, Khanfar MA. Multi-drug resistant Acinetobacter baumannii: phenotypic and genotypic resistance profiles and the associated risk factors in teaching hospital in Jordan. J Infect Public Health. 2024, 17:543-50. 10.1016\/j.jiph.2024.01.018","journal-title":"J Infect Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202501.1332.v2","article-title":"Prevalence of multidrug-resistant Acinetobacter baumannii and it\u2019s molecular characterization in hospitalized patients in a governmental hospital in Irbid, Jordan [PREPRINT]","author":"Al\u2011Groom RM","year":"2025","unstructured":"Al\u2011Groom RM, Alkofahi OH, Saghir SA, et al.. Prevalence of multidrug-resistant Acinetobacter baumannii and it\u2019s molecular characterization in hospitalized patients in a governmental hospital in Irbid, Jordan [PREPRINT]. 2025, 10.20944\/preprints202501.1332.v2"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1519906","article-title":"An integrative review on the risk factors, prevention, and control strategies for carbapenem-resistant Acinetobacter baumannii colonization in critically ill patients","volume":"15","author":"Zhang S","year":"2024","unstructured":"Zhang S, Xiao J, Li Y, et al.. An integrative review on the risk factors, prevention, and control strategies for carbapenem-resistant Acinetobacter baumannii colonization in critically ill patients. Front Microbiol. 2024, 15:1519906. 10.3389\/fmicb.2024.1519906","journal-title":"Front Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1511122","article-title":"Acinetobacter baumannii infection in critically ill patients with COVID-19 from Tehran, Iran: the prevalence, antimicrobial resistance patterns and molecular characteristics of isolates","volume":"14","author":"Ghamari M","year":"2024","unstructured":"Ghamari M, Jabalameli F, Afhami S, Halimi S, Emaneini M, Beigverdi R. Acinetobacter baumannii infection in critically ill patients with COVID-19 from Tehran, Iran: the prevalence, antimicrobial resistance patterns and molecular characteristics of isolates. Front Cell Infect Microbiol. 2024, 14:1511122. 10.3389\/fcimb.2024.1511122","journal-title":"Front Cell Infect Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107605","article-title":"Acinetobacter baumannii: a comprehensive review of global epidemiology, clinical implications, host interactions, mechanisms of antimicrobial resistance and mitigation strategies","volume":"204","author":"Sharma R","year":"2025","unstructured":"Sharma R, Lakhanpal D. Acinetobacter baumannii: a comprehensive review of global epidemiology, clinical implications, host interactions, mechanisms of antimicrobial resistance and mitigation strategies. Microb Pathog. 2025, 204:107605. 10.1016\/j.micpath.2025.107605","journal-title":"Microb Pathog"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","author":"Sati H","year":"2025","unstructured":"Sati H, Carrara E, Savoldi A, et al.. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. 2025, 10.1016\/S1473-3099(25)00118-5","journal-title":"Lancet Infect Dis"},{"key":"ref8","unstructured":"World Health Organization. WHO updates list of drug\u2011resistant bacteria most threatening to human health. (2024). Accessed. July 2025: https:\/\/www.who.int\/news\/item\/17-05-2024-who-updates-list-of-drug-resistant-bacteria-most-threatening-to-human-health."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106707","article-title":"Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020","volume":"61","author":"Chen CH","year":"2023","unstructured":"Chen CH, Wu PH, Lu MC, Ho MW, Hsueh PR. Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020. Int J Antimicrob Agents. 2023, 61:106707. 10.1016\/j.ijantimicag.2022.106707","journal-title":"Int J Antimicrob Agents"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1332108","article-title":"Acinetobacter baumannii: an evolving and cunning opponent","volume":"15","author":"Shi J","year":"2024","unstructured":"Shi J, Cheng J, Liu S, Zhu Y, Zhu M. Acinetobacter baumannii: an evolving and cunning opponent. Front Microbiol. 2024, 15:1332108. 10.3389\/fmicb.2024.1332108","journal-title":"Front Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1408959","article-title":"Clinical outcomes and risk factors of Acinetobacter baumannii meningitis in pediatric patients at a tertiary hospital in China","volume":"14","author":"Wang Z","year":"2024","unstructured":"Wang Z, Ye L, Fu P, et al.. Clinical outcomes and risk factors of Acinetobacter baumannii meningitis in pediatric patients at a tertiary hospital in China. Front Cell Infect Microbiol. 2024, 14:1408959. 10.3389\/fcimb.2024.1408959","journal-title":"Front Cell Infect Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1395260","article-title":"Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii","volume":"14","author":"Zhang S","year":"2024","unstructured":"Zhang S, Di L, Qi Y, Qian X, Wang S. Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii. Front Cell Infect Microbiol. 2024, 14:1395260. 10.3389\/fcimb.2024.1395260","journal-title":"Front Cell Infect Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00184-6","article-title":"Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)","volume":"23","author":"Kaye KS","year":"2023","unstructured":"Kaye KS, Shorr AF, Wunderink RG, et al.. Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK). Lancet Infect Dis. 2023, 23:1072-84. 10.1016\/S1473-3099(23)00184-6","journal-title":"Lancet Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2022.05.011","article-title":"In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance","volume":"30","author":"Findlay J","year":"2022","unstructured":"Findlay J, Poirel L, Bouvier M, Nordmann P. In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance. J Glob Antimicrob Resist. 2022, 30:445-50. 10.1016\/j.jgar.2022.05.011","journal-title":"J Glob Antimicrob Resist"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02142-21","article-title":"Cefiderocol- compared to colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii","volume":"66","author":"Falcone M","year":"2022","unstructured":"Falcone M, Tiseo G, Leonildi A, et al.. Cefiderocol- compared to colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2022, 66:e0214221. 10.1128\/aac.02142-21","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09335-8","article-title":"Risk factors for bacteremic pneumonia and mortality (28-day mortality) in patients with Acinetobacter baumannii bacteremia","volume":"24","author":"Lan M","year":"2024","unstructured":"Lan M, Dongmei K, Guodong S, Haifeng Y, Guofeng C, Mengting C, Xiaoyun F. Risk factors for bacteremic pneumonia and mortality (28-day mortality) in patients with Acinetobacter baumannii bacteremia. BMC Infect Dis. 2024, 24:448. 10.1186\/s12879-024-09335-8","journal-title":"BMC Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13080784","article-title":"Challenges facing two outbreaks of carbapenem-resistant Acinetobacter baumannii: from cefiderocol susceptibility testing to the emergence of cefiderocol-resistant mutants","volume":"13","author":"Rodr\u00edguez-Aguirregabiria M","year":"2024","unstructured":"Rodr\u00edguez-Aguirregabiria M, L\u00e1zaro-Perona F, Cacho-Calvo JB, et al.. Challenges facing two outbreaks of carbapenem-resistant Acinetobacter baumannii: from cefiderocol susceptibility testing to the emergence of cefiderocol-resistant mutants. Antibiotics (Basel). 2024, 13:784. 10.3390\/antibiotics13080784","journal-title":"Antibiotics (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01424-21","article-title":"Case commentary: uncertainty in evaluating treatment outcomes in carbapenem-resistant Acinetobacter baumannii infections","volume":"65","author":"Howard-Anderson J","year":"2021","unstructured":"Howard-Anderson J, van Duin D. Case commentary: uncertainty in evaluating treatment outcomes in carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2021, 65:e0142421. 10.1128\/AAC.01424-21","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10781-1","article-title":"Mortality and clinical outcomes of colistin versus colistin-based combination therapy for infections caused by multidrug-resistant Acinetobacter baumannii in critically ill patients","volume":"25","author":"Alwazzeh MJ","year":"2025","unstructured":"Alwazzeh MJ, Algazaq J, Al-Salem FA, et al.. Mortality and clinical outcomes of colistin versus colistin-based combination therapy for infections caused by multidrug-resistant Acinetobacter baumannii in critically ill patients. BMC Infect Dis. 2025, 25:416. 10.1186\/s12879-025-10781-1","journal-title":"BMC Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-025-05137-1","article-title":"Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study","volume":"44","author":"Russo A","year":"2025","unstructured":"Russo A, Serapide F, Alessandri F, et al.. Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study. Eur J Clin Microbiol Infect Dis. 2025, 44:1667-76. 10.1007\/s10096-025-05137-1","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/388989-atypical-presentation-of-multidrug-resistant-acinetobacter-baumannii-pneumonia-in-a-post-surgical-icu-patient-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:21:39Z","timestamp":1753885299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/388989-atypical-presentation-of-multidrug-resistant-acinetobacter-baumannii-pneumonia-in-a-post-surgical-icu-patient-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.89059","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}